Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145716 | SCV000192834 | pathogenic | Rubinstein-Taybi syndrome due to CREBBP mutations | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Wessex Regional Genetics Laboratory, |
RCV000145716 | SCV000999406 | pathogenic | Rubinstein-Taybi syndrome due to CREBBP mutations | 2019-11-05 | criteria provided, single submitter | clinical testing | |
Institute for Genomic Medicine |
RCV000145716 | SCV001423644 | pathogenic | Rubinstein-Taybi syndrome due to CREBBP mutations | 2017-11-04 | criteria provided, single submitter | clinical testing | [ACMG/AMP: PVS1, PS2, PM2, PP5] This alteration is a null variant in a gene where LOF is a known mechanism of disease [PVS1], is de novo in origin as it was not detected in the submitted parental specimens (identity confirmed) [PS2], is absent from or rarely observed in large-scale population databases [PM2], was reported as a pathogenic/likely pathogenic alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory) [PP5]. |
3billion, |
RCV000145716 | SCV002058584 | pathogenic | Rubinstein-Taybi syndrome due to CREBBP mutations | 2022-01-03 | criteria provided, single submitter | clinical testing | Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000158338, PMID:16021471, 3billion dataset). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Gene |
RCV001824287 | SCV002073967 | pathogenic | not provided | 2023-05-18 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 16021471, 32827181, 32371413) |